Skip to main content

NCT00723528 - A Placebo-Controlled Double-Blind Comparative Study of CNTO1275 in Patients With Plaque Type Psoriasis

A Placebo-Controlled Double-Blind Comparative Study of CNTO1275 in Patients With Plaque Type Psoriasis


CSR Summary

Not Yet Available


Data Specification

Not Available


Annotated CRF

Not Available

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.

Product Info

Generic Name
Ustekinumab
Product Name
STELARA®
Therapeutic Area
Skin and Connective Tissue Diseases
Enrollment
158
% Female
19.7%
% White
N/A
Product Class
Antipsoriatics
Sponsor Protocol Number
JNS009-JPN-02
Data Holder
Johnson & Johnson
Condition Studied
Psoriasis
Mean/Median Age (Years)
46.0

Supporting Documentation

Data Definition Specification Available
Annotated Case Report Form Available
Clinical Study Report
Statistical Analysis Plan
Study Phase 
3
Additional Information: 

Please note: individual participant-level data are not available for this trial. Only the statistical analysis plan and full clinical study report are available.

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.